How do you pay?

How to pay the least

Ask for the cash price

Generic gefitinib

Only Amazon Pharmacy posts a price for gefitinib 250 mg, 30 tablets, and it’s for members.

  1. Ask your pharmacy: “What’s your cash price for generic gefitinib 250 mg, 30 tablets?”Find pharmacies near you 
  2. Ask one or two other pharmacies too. Cash prices for the same generic can differ a lot from store to store.

With a membership $3,915.60 for 30 tablets from Amazon Pharmacy, by mail ($139 a year).

Open Amazon Pharmacy 

A regular generic has the same active ingredient as Iressa, and the FDA requires it to work the same way.

Compare every option

Question
Brand nameIressa
Authorized genericgefitinib
Regular genericgefitinib
What you’d pay
Cash priceAsk the pharmacyUsually the highest price
Not soldThere isn’t one
Cash priceMembers only$3,915.60 for 30 tablets at Amazon Pharmacy
Same as Iressa?
The original
–
Same active ingredientFillers and dyes can differ

Brand nameNo maker’s card

We didn’t find a savings card or cash price from Iressa’s maker. Ask the pharmacy for Iressa’s cash price. With insurance, ask what your plan charges.

Authorized genericNot sold

There isn’t one. An authorized generic is Iressa itself, from the same company, sold without the brand name, and usually for less. A regular generic is sold, with the same active ingredient: ask the pharmacy for its price.

See the regular generic →

Regular genericWhere to buy it

Pharmacies’ own cash prices for generic gefitinib, lowest first.

Delivered

From each pharmacy’s own site, read November 2, 2026. Confirm the price before you fill.

About these prices

Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.

Regular genericWho makes it

3 companies sell a generic of Iressa that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.

It’s mostly filled by specialty pharmacies. Your prescriber’s office or insurer can tell you which one to use.

  • Ingenus Pharmaceuticals250 mg

    Has lactose · Made by Qilu Pharm Hainan

    How it looks, what’s in it, NDCs

    250 mg Brown, round, 11 mm, marked “QL”

    PackageNDC
    Bottle of 3050742-366-30

    Inactive ingredients: lactose monohydrate, cellulose, microcrystalline, croscarmellose sodium, povidone k30, sodium lauryl sulfate, magnesium stearate, polyvinyl alcohol, polyethylene glycol 3350, talc, titanium dioxide, ferric oxide red, ferrosoferric oxide, ferric oxide yellow

    FDA label

  • Natco Pharma250 mg

    Has lactose

    How it looks, what’s in it, NDCs

    250 mg Brown, round, 11 mm, marked “N / 250”

    PackageNDC
    Bottle of 3069339-168-03

    Inactive ingredients: lactose monohydrate, microcrystalline cellulose 101, microcrystalline cellulose 102, croscarmellose sodium, povidone k30, sodium lauryl sulfate, magnesium stearate, polyvinyl alcohol, polyethylene glycol, talc, ferric oxide yellow, ferric oxide red, titanium dioxide

    FDA label

  • Teva Pharmaceuticals250 mg

    Has lactose · Made by Actavis Laboratories FL

    How it looks, what’s in it, NDCs

    250 mg Light brown to brown, round, 11 mm, marked “250”

    PackageNDC
    Bottle of 300480-4053-56

    Inactive ingredients: croscarmellose sodium, lactose monohydrate, magnesium stearate, microcrystalline cellulose, povidone, sodium lauryl sulfate, polyethylene glycol 3350, polyvinyl alcohol, ferric oxide red, talc, titanium dioxide, ferric oxide yellow

Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.

What to say at the pharmacy

“Before you fill my Iressa, can you tell me what I’d pay for the brand and for a generic?”

Paying cash? Ask for each one’s cash price. With insurance, ask what your plan charges for each.

What it’s used for

What the FDA label says

IRESSA is a tyrosine kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test.

Limitation of Use: Safety and efficacy of IRESSA have not been established in patients whose tumors have EGFR mutations other than exon 19 deletions or exon 21 (L858R) substitution mutations.

Source: the FDA label for Iressa (AstraZeneca Pharmaceuticals LP), February 28, 2023. Full label on DailyMed 

Good to know